Real-world (RW) systemic treatment patterns and clinical outcomes in locally advanced (LA) and recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC) patients (pts).

被引：0
|
作者：
Thao Vo
Boyd, Marley
Espirito, Janet L.
Gumuscu, Burak
Chirovsky, Diana Romana
Robert, Nicholas J.
Swaby, Ramona F.
Zhou, Wei
Cowey, Charles Lance
机构：
[1] Merck, Kenilworth, NJ USA
[2] McKesson Life Sci, The Woodlands, TX USA
[3] Merck & Co Inc, Kenilworth, NJ USA
[4] Merck & Co Inc, Jersey City, NJ USA
[5] Baylor Sammons Canc Ctr TOPA, Frisco, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19284
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Real-world treatment patterns and clinical outcomes in advanced cutaneous melanoma patients in France
    Sassolas, B.
    Leccia, M. T.
    Godard, C.
    Benmahamed, L.
    Flinois, A.
    Levy-Bachelot, L.
    Bedane, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (04) : 587 - 594
  • [22] Real-world (RW) treatment (tx) patterns and outcomes in patients (pts) from Taiwan and Singapore with intermediate and advanced hepatocellular carcinoma (HCC)
    Choo, S. P.
    Mhatre, S. K.
    Ferro, A.
    Machado, R.
    Liu, D. H-C.
    Irahara, N.
    Gaillard, V. E.
    Shao, Y-Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S1309 - S1310
  • [23] Real-world (rw) treatment patterns, sequencing, and outcomes in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) receiving avelumab first-line maintenance (1LM) in the US.
    Moon, Helen H.
    Kearney, Mairead
    Mahmoudpour, Seyed Hamidreza
    Ike, Chiemeka
    Morris, Valerie A.
    Rava, Andrew
    Kim, Sonia
    Sun, Haiyan
    Boyd, Marley
    Rey, Gabriel Gomez
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 605 - 605
  • [24] Real-World Treatment Patterns and Clinical Outcomes in Advanced/Metastatic NSCLC Patients in England
    Verleger, Katharina
    Hertel, Nadine
    Solem, Caitlyn
    Penrod, John R.
    Macahilig, Cynthia
    Luo, Linlin
    Crawford, S. Michael
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 5 - 5
  • [25] Real-World Treatment Patterns and Outcomes in Patients Receiving Second-Line Therapy for Advanced/Metastatic Esophageal Squamous Cell Carcinoma
    Abraham, Pranav
    Gricar, Joe
    Zhang, Ying
    Shankaran, Veena
    ADVANCES IN THERAPY, 2020, 37 (07) : 3392 - 3403
  • [26] Real-World Treatment Patterns and Outcomes in Patients Receiving Second-Line Therapy for Advanced/Metastatic Esophageal Squamous Cell Carcinoma
    Pranav Abraham
    Joe Gricar
    Ying Zhang
    Veena Shankaran
    Advances in Therapy, 2020, 37 : 3392 - 3403
  • [27] KEYNOTE-629: Efficacy of pembrolizumab (Pembro) per immune-related RECIST (irRECIST) in locally advanced (LA) and recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC)
    Munoz Couselo, E.
    Hughes, B. G. M.
    Bratland, A.
    Gutzmer, R.
    Roshdy, O.
    Gonzalez Mendoza, R.
    Schachter, J.
    Arance Fernandez, A. M.
    Grange, F.
    Meyer, N.
    Joshi, A. J.
    Billan, S.
    Grob, J. J.
    Zhang, P.
    Gumuscu, B.
    Swaby, R.
    Mortier, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S1444 - S1445
  • [28] Real-World Metastatic Renal Cell Carcinoma Treatment Patterns and Clinical Outcomes in The Netherlands
    van Laar, S. A.
    Gombert-Handoko, K. B.
    Groenwold, R. H. H.
    van der Hulle, T.
    Visser, L. E.
    Houtsma, D.
    Guchelaar, H. J.
    Zwaveling, J.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [29] Pembrolizumab (pembro) for locally advanced (LA) or recurrent/metastatic (R/M) cutaneous squamous cell carcinoma (cSCC): Long-term results of the phase 2 KEYNOTE-629 study
    Couselo, Eva Munoz
    Hughes, Brett Gordon Maxwell
    Mortier, Laurent
    Grob, Jean-Jacques
    Gutzmer, Ralf
    Roshdy, Osama
    Mendoza, Rene Lazaro Gonzalez
    Schachter, Jacob
    Arance, Ana Maria
    Grange, Florent
    Meyer, Nicolas
    Joshi, Abhishek Jagdish
    Billan, Salem
    Ojavee, Sven Erik
    Yuan, Jianda
    Gumuscu, Burak
    Bratland, Ase
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Real-world (RW) treatment (Tx) patterns and clinical outcomes in patients (pts) with metastatic urothelial carcinoma (mUC): Results of a nationwide, longitudinal, retrospective study in Hungary
    Maraz, A. C.
    Nagy, B.
    Macher, T.
    Jesko, J.
    Tischler, E.
    Csongvai, C.
    Kearney, M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1341 - S1341
12345